HC Wainwright & Co. reiterated coverage on Kala Pharmaceuticals with a new price target

5/6/21 7:31:45 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Kala Pharmaceuticals with a rating of Buy and set a new price target of $14.00 from $16.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$KALA

Date	Price Target	Rating	Analyst
3/30/2022		Neutral → Underweight	JP Morgan
8/6/2021	$14.00 → $11.00	Buy	HC Wainwright & Co.
8/6/2021		Overweight → Neutral	JP Morgan